Growth Metrics

Palvella Therapeutics (PVLA) Cash & Equivalents (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Palvella Therapeutics 1.47 Bn 1.21 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 255.96%
Dec 31, 2025 -8.79%
Sep 30, 2025 -9.75%
Jun 30, 2025 -6.87%
Mar 31, 2025 -9.54%
Dec 31, 2024 488.46%
Sep 30, 2024 -2.27%
Jun 30, 2024 132.67%
Mar 31, 2024 -14.99%
Dec 31, 2023 -83.59%
Sep 30, 2023 -18.40%
Jun 30, 2023 38.14%
Mar 31, 2023 2.87%
Dec 31, 2022 -20.21%
Sep 30, 2022 -10.75%
Jun 30, 2022 -35.21%
Mar 31, 2022 -28.89%
Dec 31, 2021 237.43%
Sep 30, 2021 -61.98%
Jun 30, 2021 37.35%
Mar 31, 2021 -5.11%
Dec 31, 2020 5.30%
Sep 30, 2020 50.99%
Jun 30, 2020 -6.60%
Mar 31, 2020 -23.82%
Dec 31, 2019 35.15%
Sep 30, 2019 -16.09%
Jun 30, 2019 5.39%
Mar 31, 2019 -27.59%
Dec 31, 2018 -19.60%
Sep 30, 2018 76.93%
Jun 30, 2018 -53.82%
Mar 31, 2018 189.14%
Dec 31, 2017 -57.88%
Sep 30, 2017 78.68%
Jun 30, 2017 -8.90%
Mar 31, 2017 88.18%
Dec 31, 2016 -19.70%
Sep 30, 2016 -9.45%
Jun 30, 2016 29.45%
Mar 31, 2016 6.26%
Dec 31, 2015 -9.01%
Sep 30, 2015 221.67%
Jun 30, 2015 -23.85%
Mar 31, 2015 -28.73%
Dec 31, 2014 1,873.35%
Sep 30, 2014 -36.96%
Jun 30, 2014 -54.59%
Mar 31, 2014 -11.37%
Dec 31, 2013 536,147.38%
Sep 30, 2013 -86.77%